141 related articles for article (PubMed ID: 24250439)
1. Physical and Chemical Stability of Mycophenolate Mofetil (MMF) Suspension Prepared at the Hospital.
Fahimi F; Baniasadi S; Mortazavi SA; Dehghan H; Zarghi A
Iran J Pharm Res; 2012; 11(1):171-5. PubMed ID: 24250439
[TBL] [Abstract][Full Text] [Related]
2. Stability of mycophenolate mofetil as an extemporaneous suspension.
Venkataramanan R; McCombs JR; Zuckerman S; McGhee B; Pisupati J; Dice JE
Ann Pharmacother; 1998; 32(7-8):755-7. PubMed ID: 9681090
[TBL] [Abstract][Full Text] [Related]
3. The stability of quetiapine oral suspension compounded from commercially available tablets.
Tran J; Gervase MA; Evans J; Deville R; Dong X
PLoS One; 2021; 16(8):e0255963. PubMed ID: 34375349
[TBL] [Abstract][Full Text] [Related]
4. Investigation of the Physical, Chemical and Microbiological Stability of Losartan Potassium 5 mg/mL Extemporaneous Oral Liquid Suspension.
Foley L; Toney J; Barlow JW; O'Connor M; Fitzgerald-Hughes D; Ramtoola Z
Molecules; 2021 Jan; 26(2):. PubMed ID: 33435555
[TBL] [Abstract][Full Text] [Related]
5. Stability of an alternative extemporaneous captopril fast-dispersing tablet formulation versus an extemporaneous oral liquid formulation.
Pabari RM; McDermott C; Barlow J; Ramtoola Z
Clin Ther; 2012 Nov; 34(11):2221-9. PubMed ID: 23149007
[TBL] [Abstract][Full Text] [Related]
6. Extemporaneous benznidazole oral suspension prepared from commercially available tablets for treatment of Chagas disease in paediatric patients.
García MC; Manzo RH; Jimenez-Kairuz AF
Trop Med Int Health; 2015 Jul; 20(7):864-70. PubMed ID: 25784402
[TBL] [Abstract][Full Text] [Related]
7. A new esomeprazole packet (sachet) formulation for suspension: in vitro characteristics and comparative pharmacokinetics versus intact capsules/tablets in healthy volunteers.
Bladh N; Blychert E; Johansson K; Backlund A; Lundin C; Niazi M; Pettersson G; Fjellman M
Clin Ther; 2007 Apr; 29(4):640-9. PubMed ID: 17617287
[TBL] [Abstract][Full Text] [Related]
8. Bioequivalence and pharmacokinetic comparison of two mycophenolate mofetil formulations in healthy Chinese male volunteers: an open-label, randomized-sequence, single-dose, two-way crossover study.
Zhang Q; Tao Y; Zhu Y; Zhu D
Clin Ther; 2010 Jan; 32(1):171-8. PubMed ID: 20171422
[TBL] [Abstract][Full Text] [Related]
9. Patient-friendly extemporaneous formulation of bisoprolol: application to stability and bioavailability studies.
El-Masry SM; Helmy SA; Helmy SAM; Mazyed EA
Drug Deliv Transl Res; 2023 Mar; 13(3):795-810. PubMed ID: 36192532
[TBL] [Abstract][Full Text] [Related]
10. Stability of extemporaneous sulfadiazine oral suspensions from commercially available tablets for treatment of congenital toxoplasmosis.
Soares Rodrigues Costa B; Pontes do Nascimento L; Vítor de Paiva Amorim M; Barreto Gomes AP; Mafra Veríssimo L
Trop Med Int Health; 2020 Mar; 25(3):364-372. PubMed ID: 31802579
[TBL] [Abstract][Full Text] [Related]
11. Alternative formulations of sorafenib for use in children.
Navid F; Christensen R; Inaba H; Li L; Chen Z; Cai X; Regel J; Baker SD
Pediatr Blood Cancer; 2013 Oct; 60(10):1642-6. PubMed ID: 23788485
[TBL] [Abstract][Full Text] [Related]
12. Formulation and Stability Study of Eslicarbazepine Acetate Oral Suspensions for Extemporaneous Compounding.
Zhao F; Dave VS; Mar MZ; Perri JR
Int J Pharm Compd; 2018; 22(5):433-439. PubMed ID: 30384342
[TBL] [Abstract][Full Text] [Related]
13. Stability of amlodipine besylate in two liquid dosage forms.
Nahata MC; Morosco RS; Hipple TF
J Am Pharm Assoc (Wash); 1999; 39(3):375-7. PubMed ID: 10363465
[TBL] [Abstract][Full Text] [Related]
14. Influence of ferrous sulfate on the solubility, partition coefficient, and stability of mycophenolic acid and the ester mycophenolate mofetil.
Lidgate D; Brandl M; Holper M; Abubakari A; Wu X
Drug Dev Ind Pharm; 2002 Nov; 28(10):1275-83. PubMed ID: 12476873
[TBL] [Abstract][Full Text] [Related]
15. Stability of hydrocortisone oral suspensions prepared from tablets and powder.
Fawcett JP; Boulton DW; Jiang R; Woods DJ
Ann Pharmacother; 1995 Oct; 29(10):987-90. PubMed ID: 8845559
[TBL] [Abstract][Full Text] [Related]
16. Stability of dantrolene oral suspension prepared from capsules.
Fawcett JP; Stark G; Tucker IG; Woods DJ
J Clin Pharm Ther; 1994 Dec; 19(6):349-53. PubMed ID: 7876365
[TBL] [Abstract][Full Text] [Related]
17. Stability of extemporaneous enalapril maleate suspensions for pediatric use prepared from commercially available tablets.
Sosnowska K; Winnicka K; Czajkowska-Kośnik A
Acta Pol Pharm; 2009; 66(3):321-6. PubMed ID: 19645333
[TBL] [Abstract][Full Text] [Related]
18. Tablet or capsule form of generic mycophenolate mofetil (My-Rept
Kim JM; Oh JW; Kim S; Rhu J; Lee JS; Kim KS; Choi GS; Joh JW
Drug Des Devel Ther; 2019; 13():2187-2193. PubMed ID: 31308630
[TBL] [Abstract][Full Text] [Related]
19. Use of Mycophenolate Mofetil Suspension as Part of Induction Therapy After Living-Donor Liver Transplant.
Harada N; Yoshizumi T; Yoshiya S; Takeishi K; Toshima T; Itoh S; Ikegami T; Fukuda M; Masuda S; Mori M
Exp Clin Transplant; 2020 Aug; 18(4):485-490. PubMed ID: 32490763
[TBL] [Abstract][Full Text] [Related]
20. Characterization of an extemporaneous liquid formulation of lisinopril.
Thompson KC; Zhao Z; Mazakas JM; Beasley CA; Reed RA; Moser CL
Am J Health Syst Pharm; 2003 Jan; 60(1):69-74. PubMed ID: 12533979
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
